Sanders Capital LLC Sells 192,342 Shares of UnitedHealth Group Incorporated $UNH

Sanders Capital LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the 3rd quarter, Holdings Channel reports. The fund owned 5,706,292 shares of the healthcare conglomerate’s stock after selling 192,342 shares during the quarter. UnitedHealth Group accounts for 2.1% of Sanders Capital LLC’s portfolio, making the stock its 16th biggest position. Sanders Capital LLC’s holdings in UnitedHealth Group were worth $2,094,666,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Alta Advisers Ltd lifted its holdings in shares of UnitedHealth Group by 80.2% during the 3rd quarter. Alta Advisers Ltd now owns 6,515 shares of the healthcare conglomerate’s stock valued at $2,392,000 after purchasing an additional 2,899 shares in the last quarter. Legacies Wealth LLC increased its stake in UnitedHealth Group by 247.4% during the 3rd quarter. Legacies Wealth LLC now owns 264 shares of the healthcare conglomerate’s stock worth $97,000 after purchasing an additional 188 shares in the last quarter. Westside Investment Management Inc. raised its holdings in UnitedHealth Group by 1.5% during the 3rd quarter. Westside Investment Management Inc. now owns 3,643 shares of the healthcare conglomerate’s stock worth $1,338,000 after buying an additional 54 shares during the period. Principle Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 1.5% in the third quarter. Principle Wealth Partners LLC now owns 27,045 shares of the healthcare conglomerate’s stock valued at $9,928,000 after buying an additional 388 shares during the period. Finally, Kestra Advisory Services LLC boosted its holdings in shares of UnitedHealth Group by 5.3% in the third quarter. Kestra Advisory Services LLC now owns 135,726 shares of the healthcare conglomerate’s stock valued at $49,822,000 after buying an additional 6,888 shares during the period. Institutional investors own 87.86% of the company’s stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: ETFs purchased $56.4 million of UNH shares on Nov. 4, a potentially supportive demand signal. ETFs Are Buying UnitedHealth (UNH) on Nov. 4
• Positive Sentiment: UnitedHealth’s Q3 adjusted EPS of $4.69 topped analyst expectations, and a recent earnings analysis said the results bolstered confidence in a margin recovery. UnitedHealth (UNH) Q3 Earnings Lift Confidence In Margin Recovery
• Positive Sentiment: A Zacks article characterized Wall Street analysts’ view of UNH as a Buy, offering a favorable sentiment signal, though the article summary did not cite a specific new rating change. Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
• Positive Sentiment: The company declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a reported yield of 2.3%. UnitedHealth Group Declares Quarterly Dividend Of $2.32 Per Share
• Negative Sentiment: Utilization and policy concerns remain an overhang for the company, highlighting uncertainty around medical costs and the regulatory environment. Utilization and Policy Concerns Weigh on UnitedHealth Group Incorporated (UNH)
• Negative Sentiment: Renewed calls for a regulatory review of UnitedHealth’s business scale, alongside warnings that AI could disrupt large healthcare companies, add longer-term risk concerns. UnitedHealth Group (UNH) Draws Breakup Pressure As AI Threat Enters The Story

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Oppenheimer raised their price objective on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Piper Sandler increased their target price on UnitedHealth Group from $502.00 to $504.00 and gave the stock an “overweight” rating in a report on Wednesday, October 14th. Raymond James Financial reaffirmed an “outperform” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research report on Thursday, October 15th. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Argus lifted their target price on UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $463.93.

UnitedHealth Group Stock Down 0.4%

Shares of UnitedHealth Group stock traded down $1.57 during trading hours on Friday, reaching $394.14. 5,901,850 shares of the company’s stock were exchanged, compared to its average volume of 6,070,064. The stock has a market cap of $353.78 billion, a P/E ratio of 22.51, a P/E/G ratio of 1.45 and a beta of 0.51. The company has a 50 day moving average of $390.62 and a two-hundred day moving average of $364.03. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The business had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group’s revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.